Next-generation biomarkers for short term risk stratification in tricuspid valve intervention
GDF-15 and suPAR provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention.
Authors
- Vera Paar (ORCID: https://orcid.org/0000-0002-4743-3220)
- Alexander Krutz (ORCID: https://orcid.org/0009-0006-1402-7492)
- Christoph Edlinger (ORCID: https://orcid.org/0000-0002-2936-2772)
- Tanja Kücken (ORCID: https://orcid.org/0000-0002-1482-951X)
- Marwin Bannehr (ORCID: https://orcid.org/0000-0001-9762-4167)
- Johannes Schlegl
- Michael Neuß
- Christian Butter
- Michael Lichtenauer
- Anja Haase-Fielitz
Institutions
- University of Salzburg (AT)
- Paracelsus Medical University (AT)
- Medizinische Hochschule Brandenburg Theodor Fontane (DE)
- Brandenburg University of Technology Cottbus-Senftenberg (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
Publication Details
- Journal
- Biomarkers in Medicine
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1080/17520363.2026.2628970
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 30.07